Bristol-Myers Squibb Company PFD CONV 2
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers drugs in various therapeutic classes, such as oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus (HIV) infection. Its products include Opdivo, a biological product for anti-cancer indications; Eliquis… Read more
Market Cap & Net Worth: Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)
Bristol-Myers Squibb Company PFD CONV 2 (PINK:BMYMP) has a market capitalization of $9.70 Million ($9.70 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #28777 globally and #9570 in its home market, demonstrating a -1.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bristol-Myers Squibb Company PFD CONV 2's stock price $1003.20 by its total outstanding shares 9671 (9.67K).
Bristol-Myers Squibb Company PFD CONV 2 Market Cap History: 2015 to 2025
Bristol-Myers Squibb Company PFD CONV 2's market capitalization history from 2015 to 2025. Data shows change from $10.39 Million to $9.70 Million (-0.72% CAGR).
Bristol-Myers Squibb Company PFD CONV 2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bristol-Myers Squibb Company PFD CONV 2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Bristol-Myers Squibb Company PFD CONV 2's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Bristol-Myers Squibb Company PFD CONV 2's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $10.39 Million | $16.56 Billion | $1.62 Billion | 0.00x | 0.01x |
| 2016 | $9.49 Million | $19.43 Billion | $4.46 Billion | 0.00x | 0.00x |
| 2017 | $9.90 Million | $20.78 Billion | $1.01 Billion | 0.00x | 0.01x |
| 2018 | $8.51 Million | $22.56 Billion | $4.95 Billion | 0.00x | 0.00x |
| 2019 | $10.92 Million | $26.14 Billion | $3.44 Billion | 0.00x | 0.00x |
| 2020 | $9.87 Million | $42.52 Billion | -$8.99 Billion | 0.00x | N/A |
| 2021 | $12.54 Million | $46.38 Billion | $6.99 Billion | 0.00x | 0.00x |
| 2022 | $11.34 Million | $46.16 Billion | $6.33 Billion | 0.00x | 0.00x |
| 2023 | $8.64 Million | $45.01 Billion | $8.03 Billion | 0.00x | 0.00x |
Competitor Companies of BMYMP by Market Capitalization
Companies near Bristol-Myers Squibb Company PFD CONV 2 in the global market cap rankings as of March 19, 2026.
Key companies related to Bristol-Myers Squibb Company PFD CONV 2 by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Bristol-Myers Squibb Company PFD CONV 2 Historical Marketcap From 2015 to 2025
Between 2015 and today, Bristol-Myers Squibb Company PFD CONV 2's market cap moved from $10.39 Million to $ 9.70 Million, with a yearly change of -0.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $9.70 Million | -0.23% |
| 2024 | $9.72 Million | +12.58% |
| 2023 | $8.64 Million | -23.80% |
| 2022 | $11.34 Million | -9.58% |
| 2021 | $12.54 Million | +26.97% |
| 2020 | $9.87 Million | -9.54% |
| 2019 | $10.92 Million | +28.22% |
| 2018 | $8.51 Million | -13.97% |
| 2017 | $9.90 Million | +4.27% |
| 2016 | $9.49 Million | -8.65% |
| 2015 | $10.39 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bristol-Myers Squibb Company PFD CONV 2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.70 Million USD |
| MoneyControl | $9.70 Million USD |
| MarketWatch | $9.70 Million USD |
| marketcap.company | $9.70 Million USD |
| Reuters | $9.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.